Hospital Padre Hurtado Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2009
NCT00935116
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now